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Abstract
Background Few studies have examined the prevalence
of lumbar spinal stenosis (LSS) in the general population.
The purposes of this study were to estimate the prevalence
of LSS and to investigate correlated factors for LSS in
Japan.
Methods A questionnaire survey was performed on 4,400
subjects selected from residents aged 40–79 years in Japan
by stratified two-stage random sampling in 2010. The
question items consisted of lower-limb symptoms sugges-
tive of LSS, the diagnostic support tool for LSS (LSS-
DST), demographic and lifestyle characteristics, comor-
bidities, the Japanese Perceived Stress Scale (JPSS), and
the Mental Health Index 5 (MHI-5). Using the LSS-DST,
the presence of LSS was predicted to estimate the preva-
lence of LSS. Logistic regression analysis was performed
to examine the relationship between LSS and correlated
factors.
Results Questionnaires were obtained from 2,666 sub-
jects (60.6 %), consisting of 1,264 males (47.4 %). The
mean (standard deviation) age was 60.0 (10.9) years.
According to the LSS-DST, 153 subjects were regarded as
having LSS. The prevalence was estimated to be 5.7 %.
When standardizing this value with the age distribution of
the Japanese population, it was estimated that 3,650,000
Japanese subjects aged 40–79 years might have LSS using
the LSS-DST. Prevalence increased with age and was
particularly high in subjects aged 70–79 years, irrespective
of gender. As correlated factors, an advanced age (60 years
or older), diabetes mellitus, urological disorders, and
osteoarthritis/fracture as comorbidities, and depressive
symptoms, were associated with LSS.
Conclusions This study elucidated the prevalence of LSS
and factors associated with LSS in Japan. This is the first
report describing the estimated prevalence of LSS and
associated factors using a strictly sampled representative
population.
Introduction
Lumbar spinal stenosis (LSS) is defined as a syndrome in
which narrowing of the spinal canal and intervertebral
foramen, which are nervous routes, related to degeneration
of the lumbar intervertebral disks and/or joints, causes
specific symptoms of the lumbar region and lower limbs
[1–3]. Patients with this disease complain of numbness and
pain in the lumbar and gluteal regions, and intermittent
claudication leads to gait disorder in some cases [2, 4].
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Although stenosis of the spinal canal is associated with
organic abnormalities, for example spondylolysis and
spondylolisthesis in some patients, aging-related degener-
ation of the vertebral bodies and/or intervertebral disks
may be etiologically involved in most patients [2]. There-
fore, this disease has been regarded as common in elderly
subjects.
However, few large-scale epidemiological surveys
involving the general population have been conducted to
investigate the prevalence of LSS, possibly because it was
difficult to apply subjects’ symptom and CT/MRI finding-
based clinical LSS diagnosis [5] to a large-scale survey.
Therefore, previous epidemiological studies had limitations
such as a small sample size or study sample restricted to
those with abnormal imaging findings [6, 7]. Furthermore,
the prevalence of LSS varied among the studies, probably
because of a lack of standardized methods and criteria for
diagnosis. Therefore, it was difficult to interpret and
compare the survey results.
In epidemiological studies on LSS in Japan, the study
samples were also limited to a population in a single city or
patients who consulted a hospital with symptoms [8–10].
Konno et al. [11] developed a diagnostic support tool for
LSS (LSS-DST) based on a self-administered questionnaire
regarding patients’ symptoms for subjects with lower-limb
symptoms suggestive of LSS. This facilitated large-scale
questionnaire surveys on the presence or absence of LSS
involving the general population.
As risk factors associated with LSS, aging, gender, and
body mass index (BMI) have been reported [12, 13].
However, these studies also involved only patients with
abnormal imaging findings of the vertebrae. Therefore, to
date, no study has investigated risk factors for LSS in the
general population.
The purpose of this study was to clarify the prevalence
of LSS-associated lower-limb symptoms, estimate the
prevalence of LSS, and investigate factors associated with
LSS, using a cross-sectional survey involving a represen-
tative sample selected from Japanese residents.
Materials and methods
Subjects
This study was the JOA-Subsidized Science Project
Research 2009 and conducted on commission from the
Japanese Orthopaedic Association. The protocol was
approved by the ethics review board of Fukushima Medical
University.
The study population consisted of all residents aged
40–79 years old in Japan who were able to respond to a
questionnaire. Sampling was performed by stratified two-
stage random sampling. Briefly, as a first step, the nation
was divided into 43 layers through a 9-area and 5-city
scale, and 200 points were selected on the basis of the
population of each regional block and/or city-scale-classi-
fied layer. As a second step, 22 subjects per point were
randomly selected from ‘‘the Basic Resident Registration’’
to obtain 4,400 representative samples. We conducted a
cross-sectional survey involving questionnaire placement
along with visits to the subjects’ homes. The survey period
was from November to December 2010.
Measurements
To examine the presence or absence of lower-limb symp-
toms associated with LSS, the following question was
initially asked: Have you experienced pain, numbness, or
flushes of the lower limbs (gluteal region, femoral region,
and lower thigh) within the last 1 month?. Simultaneously,
a figure was attached so that respondents could accurately
understand the sites of the gluteal region, femoral region,
and lower thigh. In subjects who reported the presence of
lower-limb symptoms, we predicted the presence or
absence of LSS by use of the LSS-DST. The LSS-DST
consists of 10 question items and has a sensitivity and
specificity of 84 and 78 %, respectively [11]. The items of
a self-administered history questionnaire as the LSS-DST
are shown in Table 1. Each item of the LSS-DST for
diagnosis of LSS required a response either of ‘‘1 = yes’’
or ‘‘0 = no’’. A total score of 4 on Q1–Q4 or a score[1 on
Q1–Q4 and[2 on Q5–Q10 indicated the presence of LSS.
The questionnaire included Mental Health Index 5
(MHI-5), which was measured using 5 items in the sub-
scale of the Medical Outcomes Study 36-Item Short Form
Health Survey (SF-36) [14–16]. Subjects with an MHI-5
score of 51 or lower, 52–59, and 60–67 were regarded as
having severe, moderate, and mild depressive symptoms,
respectively. To measure stress in daily living, the Japanese
Perceived Stress Scale (JPSS) [17–19] was used. This is a
scale that measures the level of perceived daily stress, but
not the stress from a life event. Using the total JPSS score,
the level of perceived stress was classified into 3 groups:
weak (\18), moderate (C18, \23), and strong (C23). The
questionnaire also included questions about age, gender,
comorbidities, educational background, household income,
marital status, smoking status, and alcohol consumption.
Statistical analysis
The prevalence of lower-limb symptoms associated with
LSS is presented. On the basis of the presence or absence
of LSS predicted using the LSS-DST, we estimated the
prevalence of LSS in the Japanese population. In addition,
on the basis of the population with regard to age in Japan in
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2010 (Statistics Bureau, Ministry of Internal Affairs and
Communications) [20], the data were standardized using
the direct method to estimate the number of patients with
LSS in Japan.
Multivariate logistic regression analysis was performed
to examine risk factors for LSS. In this model, age, gender,
comorbidities, educational background, household income,
marital status, smoking, alcohol consumption, perceived
daily stress, and depressive symptoms were used as
explanatory variables. For statistical analysis, Stata SE
version 12 software (Stata, USA) was used.
Results
Of the 4,400 subjects, questionnaires were obtained from
2,666 (response 60.6 %) (Fig. 1). The mean age (standard
deviation) of the respondents was 60.0 (10.9) years. The
proportion of males was 47.4 %. The respondents’ char-
acteristics are shown in Table 2.
Of the respondents, 500 (18.8 %) had complained of
LSS-associated symptoms of the lower limbs (pain,
numbness, flushes) within 1 month before the survey
(Fig. 1). The prevalence of lower-limb symptoms increased
with age irrespective of gender, reaching a maximum at
70 years of age.
Of the respondents, 153 were regarded as having LSS
according to the LSS-DST (crude prevalence of 5.7 %).
With regard to age (Fig. 2), the prevalence of LSS was
estimated to be 1.9 % in respondents aged 40–49 years,
4.8 % in those aged 50–59 years, 5.5 % in those aged
60–69 years, and 10.8 % in those aged 70–79 years,
showing an increase with age. With regard to gender, the
prevalence of LSS in males and females of all ages was 5.7
and 5.8 %, respectively, showing no difference. However,
in males and females aged 70–79 years, the prevalence was
10.3 and 11.2 %, respectively, which was slightly higher in
females. Standardizing with the age distribution of the
Japanese population, the age-adjusted prevalence of LSS
using the LSS-DST was estimated to be 5.7 %, and the
number of patients with LSS was estimated to be
3,650,000, among Japanese aged 40–79 years. The preva-
lence of LSS estimated with regard to residential area and
urban scale is shown in Table 3. With regard to residential
area, the prevalence in the Kanto (6.4 %) and Kinki
(7.6 %) regions, in which the Japanese population is con-
centrated, was estimated to be high. However, with regard
to urban scale, there were no notable trends in the esti-
mated prevalence of LSS.
Among the respondents, we compared their character-
istics between subjects who were regarded as having LSS
by use of the LSS-DST and those who were not regarded as
having LSS (non-LSS) (Table 4). In the subjects with LSS,
the mean age was more advanced, and the number of
comorbidities was greater. Among the comorbidities
examined, hypertension, diabetes, cardiovascular diseases
(myocardial infarction, stroke, and angina pectoris), oph-
thalmic disorder, gastrointestinal disorder, urological dis-
order, osteoarthritis/fracture, neurological disorder, and
osteoporosis were concomitantly present in larger propor-
tions of subjects with LSS than in those without (non-LSS).
The associations of the subjects’ characteristics and
mental factors with the presence of LSS are shown in
Table 5. The adjusted odds ratio of LSS increased with
age. In subjects aged 70–79 years, it was 5.38 times higher
than that in those aged 40–49 years (95 % confidence
Table 1 The items of a self-administered, self-reported history
questionnaire (SSHQ) as a diagnostic support tool for LSS
Item
Q1 Numbness and/or pain in the thighs down to the calves and
shins
Q2 Numbness and/or pain increase in intensity after walking for a
while, but are relieved by taking a rest
Q3 Standing for a while brings on numbness and/or pain in the
thighs down to the calves and shins
Q4 Numbness and/or pain are reduced by bending forward
Q5 Numbness is present in both legs
Q6 Numbness is present in the soles of both feet
Q7 Numbness arises around the buttocks
Q8 Numbness is present, but pain is absent
Q9 A burning sensation arises around the buttocks
Q10 Walking nearly causes urination
Sample n=4,400
Responder n=2,666
Symptoms(+)
n=500
Symptoms(-)
n=2,166
LSS-DST
LSS (+)
n=153
LSS (−)
n=347
The presence or absence of lower-limb symptoms
LSS(−)
n=2,513
Stratified two-stage random sampling
Study Population
Japanese residents, Aged 40 to 79 years
Fig. 1 Flow chart of the population-based study for prevalence of
lumbar spinal stenosis (LSS)
Prevalence of LSS in Japan 895
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interval (95 %CI) 2.03–14.21, respectively). There were no
significant associations with gender or BMI. Concerning
the number of comorbidities, the crude odds ratio was 3.38
in subjects with 2 or more comorbidities. However, the
adjusted odds ratio of this association was not significant.
With regard to individual comorbidities, there was an
increase in the adjusted odds ratio in the presence of uro-
logic disorder (2.17, 95 %CI 1.10–4.29), diabetes mellitus
(2.05; 95 % CI: 1.14–3.67), and osteoarthritis/fracture
(2.71, 95 % CI 1.53–4.82). In subjects with severe
depressive symptoms as a mental factor, the adjusted odds
ratio was 3.55 (95 % CI 1.97–6.40).
Discussion
This study showed that in Japanese aged 40 to 79 years the
prevalence of LSS-associated lower-limb symptoms was
18.8 %; the prevalence of LSS was estimated to be 5.7 %
using the diagnostic support tool; and the number of
patients with LSS was estimated to be 3,650,000.
Yamazaki [8] reported that the prevalence of LSS was
12.5 %, but their survey was limited to a single city, and
the mean age was 67.9 years, more advanced than for the
population in this study. This may have contributed to the
higher reported prevalence. In this study, a sample repre-
senting the Japanese population was selected by a stratified
two-stage random sampling method. The response was
60.6 %. Furthermore, there were no differences in gender
or age distribution between responders and non-responders.
Therefore, the results of this study can be generalized to
Japanese aged 40–79 years. In previous epidemiological
studies, prevalence of LSS of 1.7–22.5 % was reported.
Kalichman et al. reported prevalence of 22.5 % using data
from the Framingham Heart Study. They diagnosed LSS by
using multidetector computed tomography (CT) to assess
coronary and aortic calcification, irrespective of the pres-
ence or absence of clinical symptoms in the lower limbs. In
this study a subject could be diagnosed as having LSS only
when he/she complained symptoms in the lower limbs.
Therefore, we might have detected clinically more relevant
patients with LSS.
Table 2 Characteristics of
subjects (n = 2,666)
SD Standard deviation, BMI
body mass index, JPY Japanese
yen, JPS Japanese Perceived
Stress Scale, MHI-5 Mental
Health Inventory-5
n (%) n (%)
Age (mean ± SD = 60.0 ± 10.9) Marital status
40–49 572 (21.5) Unmarried 180 (6.8)
50–59 694 (26.0) Married 2,056 (77.1)
60–69 789 (29.6) Separated/divorced/bereaved 363 (13.6)
70–79 611 (22.9) Smoking status
Sex Never 1,790 (67.1)
Male 1,264 (47.4) Past 180 (6.8)
Female 1,402 (52.6) Current 574 (21.5)
BMI (kg/m2) Alcohol drinking
\18 129 (4.8) Hardly ever or never 1,441 (54.1)
C18, \22 988 (37.1) Sometimes 469 (17.6)
C22, \25 916 (34.4) Almost every day 683 (25.6)
C25, \30 458 (17.2) Exercise habit
C30 175 (6.6) No 1,300 (48.8)
Number of comorbidities Yes 1,253 (47.0)
0 984 (36.9) Occupation
1 713 (26.7) No 1,536 (57.6)
2B 969 (36.4) Yes 1,067 (40.0)
Educational level Perceived Stress (JPSS)
Elementary-high school 1,191 (44.7) Low (\18) 815 (30.6)
Professional school, Junior college 327 (12.3) Moderate (18–22) 756 (28.4)
University or above 360 (13.5) Severe (C23) 1,095 (41.1)
Household income (JPY) Depressive symptoms (MHI-5)
\3,000,000 645 (24.2) None (C68) 1,635 (61.3)
3,000,000B, \5,000,000 665 (24.9) Low (60–67) 424 (15.9)
5,000,000B, \7,000,000 461 (17.3) Moderate (52–59) 168 (6.3)
7,000,000B 633 (23.7) Severe (\52) 380 (14.3)
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The estimated prevalence of LSS increased with age
irrespective of gender. In particular, among elderly sub-
jects, the prevalence in females was slightly higher than in
males. This was consistent with the results of a previous
study [12]. One reason to explain the slightly higher
prevalence in females could be that aging-related degen-
eration of the vertebral bodies [2], which is the major eti-
ology of LSS, may be closely related to osteoporosis in
elderly females. However, in this study, the presence or
absence of osteoporosis was not measured objectively, and
its effect could not be clarified.
This study showed that factors associated with the pres-
ence of LSS were age, some comorbidities, and severe
depressive symptoms. We found no significant associations
between BMI and the presence of LSS in this study. In
contrast Venkatesan et al. [21] reported high BMI as a risk
factor for cauda equina syndrome. The population of their
study was young (mean age of 39 years) and could include
patients with diseases other than LSS, for example lumbar
disc herniation, which may cause the association between
BMI and cauda equina syndrome. With regard to individual
comorbidities, the presence of urological disorders and
osteoarthritis/fracture was associated with the presence of
LSS. The prevalence of these conditions increased with age.
Concerning urological disorders, in addition to this, the
presence of neurogenic bladder, as an LSS-related cauda
equina symptom, may be associated. Aortic calcification
was reported to correlate with degeneration of the interver-
tebral discs and spine [22, 23]. Diabetes mellitus, one of the
causes of LSS, can also increase the risk of aortic calcifi-
cation [24], and this may be an explanation of the associa-
tion with the presence of LSS. Concerning neurological
disorders, the questionnaire asked neurological disorders as
‘‘neurological disorders such as epilepsy’’ and did not dis-
cern actual diagnoses. Therefore the neurological disorders
may have contained peripheral nerve disorders which could
cause symptoms resembling those by LSS. This is one
explanation for the association between neurological disor-
ders and LSS in this study. No study has reported an asso-
ciation between the presence of LSS and depression. In this
study, the adjusted odds ratio of severe depressive symptoms
was as high as 3.39. Sinikallio et al. [25] reported the
prevalence of depression of 20 % among the patients with
LSS which was higher than that in general population.
Guilfoyle et al. [15] reported an association between
depressive symptoms and low back pain. These findings
suggest the presence of low back pain, including LSS, may
be associated with the presence of depressive symptoms. In
this study, we elucidated the association between the level of
depressive symptoms and the presence of LSS in the rep-
resentative sample of the Japanese population, which was
allowed by using the self-reported diagnostic support tool
for LSS. Concerning the association between the presence of
LSS and perceived stress in daily living, we found no sig-
nificant association in the multivariate analysis. A previous
study has shown a low correlation between perceived stress
in daily living measured by JPSS and depressive symptoms
measured by MHI-5, suggesting that those two concepts are
different each other [19, 26]. The MHI-5 contains items
gauging psychological factors such as anxiety and stress,
whereas JPSS contains physiological items in addition to
psychological ones. Such differences may have caused the
inconsistent results of associations of JPSS and MHI-5 with
the presence of LSS shown in this study.
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Fig. 2 Estimated prevalence of lumbar spinal stenosis (LSS) with
regard to age
Table 3 The prevalence of lumbar spinal stenosis (LSS) in all sub-
jects by local areas and the population size of the cities
No. of subjects LSS(?)
n (%)
Local areas of Japan
Hokkaido 138 7 (5.1)
Tohoku 241 9 (3.7)
Kanto 849 54 (6.4)
Hokuriku 146 6 (4.1)
Tokai 337 14 (4.2)
Kinki 381 29 (7.6)
Chugoku 163 6 (3.7)
Shikoku 74 6 (8.1)
Kyusyu 337 22 (6.5)
Population size of the cities
19 Largest citiesa 625 34 (5.4)
C200,000 627 40 (6.4)
C100,000 483 27 (5.6)
\100,000 648 37 (5.7)
Rural areas 283 15 (5.3)
a The 19 largest cities are Sapporo, Sendai, Saitama, Chiba, Tokyo,
Yokohama, Kawasaki, Niigata, Shizuoka, Hamamatsu, Nagoya,
Kyoto, Osaka, Sakai, Kobe, Okayama, Hiroshima, Kitakyusyu,
Fukuoka
Prevalence of LSS in Japan 897
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This study has some limitations. First, a questionnaire
survey was used, so neither lower-limb symptoms nor LSS
could be assessed objectively. For this reason, the accuracy
of LSS diagnosis may not be particularly high. For exam-
ple, some patients having related symptoms and a disease
other than LSS, for example lumbar disc herniation, might
be misclassified as LSS. However, we used a diagnostic
support tool to predict LSS based on patients’ symptoms
for the two reasons:
1. It is impossible to diagnose LSS by use of diagnostic
imaging procedures, for example MRI, alone. Even
when imaging shows abnormal findings, clinical
symptoms can be absent in some patients [26, 27].
Table 4 Comparison of characteristics between subjects with and
without lumbar spinal stenosis (LSS)
LSS(-) LSS(?) P value
n (%) n (%)
Age (mean ± SD = 60.0 ± 10.9) \0.001
40–49 561 (22.3) 11 (7.2)
50–59 661 (26.3) 33 (21.6)
60–69 746 (29.7) 43 (28.1)
70–79 545 (21.7) 66 (43.1)
Sex 0.934
Male 1,192 (47.4) 72 (47.1)
Female 1,321 (52.6) 81 (52.9)
BMI (kg/m2) 0.113
\18 124 (4.9) 5 (3.3)
C18, \22 940 (37.4) 48 (31.4)
C22, \25 865 (34.4) 51 (33.3)
C25, \30 420 (16.7) 38 (24.8)
C30 164 (6.5) 11 (7.2)
Educational level 0.006
Elementary-high School 1,100 (43.8) 91 (59.5)
Professional school, Junior
college
314 (56.3) 13 (8.5)
University or above 346 (70.0) 14 (9.2)
Household income (JPY) 0.004
\3,000,000 593 (23.6) 52 (34.0)
3,000,000B, \5,000,000 624 (24.8) 41 (26.8)
5,000,000B, \7,000,000 446 (17.8) 15 (9.8)
7,000,000B 603 (24.0) 30 (19.6)
Marital status 0.520
Unmarried 173 (6.9) 7 (4.6)
Married 1,935 (77.0) 121 (79.1)
Separated/divorced/bereaved 340 (13.5) 23 (15.0)
Smoking status 0.786
Never 1,690 (67.3) 100 (65.4)
Past 168 (6.7) 12 (7.8)
Current 541 (21.5) 33 (21.6)
Alcohol drinking 0.788
Hardly ever or never 1,363 (54.2) 78 (51.0)
Sometimes 445 (17.7) 24 (15.7)
Almost every day 642 (25.6) 41 (26.8)
Exercise habit 0.122
No 1,236 (49.2) 64 (41.8)
Yes 1,173 (46.7) 80 (52.3)
Occupation 0.003
No 1,466 (58.3) 70 (45.8)
Yes 988 (39.3) 79 (51.6)
Perceived stress (JPSS) \0.001
Low (\18) 787 (31.3) 28 (18.3)
Moderate (18–22) 720 (28.7) 36 (23.5)
Severe (C23) 1,006 (40.0) 89 (58.2)
Table 4 continued
LSS(-) LSS(?) P value
n (%) n (%)
Depressive symptoms (MHI-5) \0.001
None (C68) 1,574 (62.6) 61 (39.9)
Low (60–67) 394 (15.7) 30 (19.6)
Moderate (52–59) 157 (6.3) 11 (7.2)
Severe (\52) 333 (13.3) 47 (30.7)
Number of comorbidities \0.001
0 954 (38.0) 30 (19.6)
1 685 (27.3) 31 (20.3)
2B 874 (34.8) 92 (60.1)
Comorbidities
Hypertension 658 (26.2) 66 (43.1) \0.001
Diabetes mellitus 199 (7.9) 30 (19.6) \0.001
Hyperlipidemia 388 (15.4) 25 (16.3) 0.731
Cardiovascular disease 161 (6.4) 24 (15.7) \0.001
Ophthalmic disorder 255 (10.2) 34 (22.2) \0.001
Respiratory disorder 124 (4.9) 12 (7.8) 0.127
Gastrointestinal disorder 267 (10.6) 25 (16.3) 0.033
Hematological disorder 146 (5.8) 10 (6.5) 0.721
Kidney disease 63 (2.5) 8 (5.2) 0.062
Urological disorder 116 (4.6) 19 (12.4) \0.001
Osteoarthritis/fracture 172 (6.8) 36 (23.5) \0.001
Rheumatoid arthritis 49 (2.0) 3 (2.0) 1.000
Dermatological disorder 109 (4.3) 8 (5.2) 0.543
Neurological disorder 7 (0.3) 3 (2.0) 0.016
Psychiatric disorder 69 (2.8) 6 (3.9) 0.443
Endocrine disorder 83 (3.3) 3 (2.0) 0.483
Pancreatic disorder 26 (1.0) 3 (2.0) 0.230
Malignant disease 79 (3.1) 7 (4.6) 0.340
Gynecological disorder 108 (4.3) 11 (7.2) 0.104
Osteoporosis 95 (3.8) 17 (11.1) \0.001
Others 98 (3.9) 12 (7.8) 0.032
SD Standard deviation, BMI body mass index, JPY Japanese yen, JPS
Japanese Perceived Stress Scale, MHI-5 Mental Health Inventory-5
898 S. Yabuki et al.
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2. No standardized diagnostic criteria for comprehensive
evaluation based on imaging findings and clinical
symptoms have been established.
The sensitivity of the LSS-DST was 84 % and it is
useful for predicting LSS in clinical settings. The
sensitivity and specificity of the LSS-DST may differ
depending on study settings. Because there are fewer
subjects with typical symptoms of LSS or with suggestive
symptoms in general populations than in clinical settings,
the sensitivity could be lower and the specificity could be
Table 5 Associations of individual factors and comorbidities with prevalence of lumbar spinal stenosis (LSS)
Crude analysisa Adjusted analysisa
OR 95 % CI P value AOR 95 % CI P value
Age (vs. 40–49)
50–59 2.55 (1.28–5.08) 0.008 2.30 (0.93–5.65) 0.070
60–69 2.94 (1.50–5.75) 0.002 2.50 (1.00–6.21) 0.049
70–79 6.18 (3.23–11.81) \0.001 5.38 (2.03–14.21) 0.001
Sex (vs. Male)
Female 1.02 (0.73–1.41) 0.928 0.93 (0.57–1.53) 0.784
BMI (vs. C22, \25)
\18 0.68 (0.27–1.75) 0.427 0.47 (0.10–2.16) 0.333
C18, \22 0.87 (0.58–1.30) 0.486 1.40 (0.81–2.40) 0.228
C25, \30 1.53 (0.99–2.37) 0.054 1.89 (1.08–3.32) 0.027
C30 1.14 (0.58–2.23) 0.707 0.78 (0.27–2.26) 0.642
Educational level (vs. elementary-high school)
Professional school, junior college 0.50 (0.28–0.91) 0.022 0.75 (0.37–1.50) 0.415
University or above 0.49 (0.28–0.87) 0.015 0.74 (0.38–1.47) 0.392
Household income (JPY) (vs. \3,000,000)
3,000,000B, \5,000,000 0.75 (0.49–1.15) 0.183 0.85 (0.49–1.46) 0.548
5,000,000B, \7,000,000 0.38 (0.21–0.69) 0.001 0.58 (0.27–1.25) 0.165
7,000,000B 0.57 (0.36–0.90) 0.017 0.88 (0.46–1.68) 0.709
Occupation (vs. no)
Yes 1.674 (1.20–2.33) 0.002 0.80 (0.47–1.36) 0.409
Perceived stress (JPSS) (vs. low)
Moderate (18–22) 1.41 (0.85–2.33) 0.186 1.47 (0.79–2.75) 0.229
Severe (C23) 2.49 (1.61–3.84) \0.001 1.50 (0.81–2.77) 0.197
Depressive symptoms (MHI-5) (vs. none)
Low (60–67) 1.96 (1.25–3.08) 0.003 1.86 (1.02–3.38) 0.043
Moderate (52–59) 1.81 (0.93–3.51) 0.080 1.34 (0.53–3.37) 0.538
Severe (\52) 3.64 (2.45–5.42) \0.001 3.55 (1.97–6.40) \0.001
Comorbidities
Hypertension 2.14 (1.53–2.98) \0.001 1.21 (0.75–1.96) 0.428
Diabetes mellitus 2.84 (1.86–4.34) \0.001 2.05 (1.14–3.67) 0.017
Cardiovascular disorder 2.72 (1.71–4.32) \0.001 1.50 (0.77–2.94) 0.234
Ophthalmic disorder 2.53 (1.69–3.78) \0.001 0.97 (0.53–1.78) 0.932
Gastrointestinal disorder 1.64 (1.05–2.57) 0.029 1.23 (0.70–2.15) 0.478
Urological disorder 2.93 (1.75–4.91) \0.001 2.17 (1.10–4.29) 0.026
Osteoarthritis, Fracture 4.19 (2.79–6.27) \0.001 2.71 (1.53–4.82) 0.001
Neurological disorder 7.16 (1.83–27.97) 0.005 7.87 (1.20–51.58) 0.031
Osteoporosis 3.18 (1.85–5.48) \0.001 0.89 (0.38–2.08) 0.792
a The crude analysis used single-variate logistic regressions whereas the adjusted analysis used multivariate logistic regression including all
explanatory variables
OR Odds ratio, AOR adjusted odds ratio, BMI body mass index, JPY Japanese yen, JPSS Japanese perceived stress test, MHI-5 Mental Health
Inventory-5
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higher. The prevalence estimated in this study may differ
from the true value and possibly have been underestimated.
In this study, LSS was predicted only in subjects who
complained of LSS-related lower-limb symptoms; there-
fore, clinically relevant LSS patients should have been
selected. Second, this was a cross-sectional study, and we
cannot indicate the causal relationship with risk factors for
the development of LSS. In the future, a longitudinal study
should be conducted to elucidate the causal relationship of
LSS with depressive symptoms, as was suggested in this
study.
In conclusion, we estimated the prevalence of LSS-
related lower-limb symptoms and LSS in a representative
sample of the Japanese population. The involvement of
mental factors in LSS was suggested, which should be
further examined in a future longitudinal study. The
prevalence of LSS will increase with further advances in
the rapid aging of society. Therefore, the prevalence of
LSS and associated factors for LSS revealed in this study
may provide information important for the future devel-
opment of medical policies.
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